BioSig Technologies, Inc. (NASDAQ: BSGM) Executive Vice President Natasha Drapeau tells Proactive the Westport, Connecticut-based medical technology company has formed its fifth R&D program collaboration with the Mayo Foundation for Medical Education and Research. Drapeau explains how the program will aim to develop Artificial Intelligence and machine learning-powered software for its PURE EP system.
BioSig forms R&D program with Mayo Clinic to develop AI and machine learning for its PURE EP System
Quick facts: BioSig Technologies, Inc.
Price: 2.85 USD
Market Cap: $99.53 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...FOR OUR FULL DISCLAIMER CLICK HERE